Document Detail

Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters myocardial substrate metabolism in conscious dogs: role of nitric oxide.
MedLine Citation:
PMID:  10630737     Owner:  NLM     Status:  MEDLINE    
We investigated the effect of bovine polymerized hemoglobin-based oxygen carrying (HBOC) solution on myocardial oxygen consumption (MVO2) and substrate use. At 15 min after the end of HBOC infusion (20% blood volume, i.v.) in nine permanently instrumented conscious dogs, mean arterial pressure and coronary blood flow were both increased by 41+/-5% and 93+/-20% (p<0.01) without affecting late diastolic coronary resistance and left ventricular dP/dtmax. Administration of HBOC did not affect arterial PO2 or O2 content, but significantly decreased coronary sinus PO2 and O2 content by 21+/-3% and 36+/-3%, respectively. MVO2 was increased from 7.2+/-0.8 to 15+/-1.8 ml O2/min (p<0.01). Despite an increase in triple product from 44+/-2 to 56+/-3 (p<0.01) 15 min after HBOC, the ratio of MVO2 and triple product was markedly elevated by 62+/-19%. Myocardial free fatty acid consumption was decreased from 14+/-1 to 4.5+/-2.2 microEq/min, whereas consumption of lactate increased from 19+/-6 to 69+/-10 micromol/ min and that of glucose increased from 1.0+/-0.5 to 10+/-3 mg/min (all p values, <0.05). These metabolic changes were not observed in dogs that received angiotensin II at a dose used (20-40 ng/kg/min, i.v.) to match those hemodynamic effects of HBOC. These results suggest that administration of HBOC increases coronary blood flow and MVO2 and shifts cardiac metabolism from using free fatty acid to using lactate and glucose in conscious dogs at rest. These metabolic changes are independent of the HBOC-induced change in hemodynamics.
K E Loke; P R Forfia; F A Recchia; X Xu; J C Osorio; M Ochoa; M Gawryl; T H Hintze
Related Documents :
2621647 - Dynamic response of the coronary circulation to a rapid change in its perfusion in the ...
1833567 - The effects of trapidil on left ventricular function and platelet aggregation in patien...
2720267 - A closed-loop system for pressure-controlled intermittent coronary sinus occlusion.
7113627 - Autoregulation of myocardial blood flow under controlled hypotension in the dog.
17620947 - Prognostic superiority of daytime ambulatory over conventional blood pressure in four p...
1236607 - The role of the kidney in essential hypertension.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  35     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2000 Jan 
Date Detail:
Created Date:  2000-02-10     Completed Date:  2000-02-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  84-92     Citation Subset:  IM    
Department of Physiology, New York Medical College, Valhalla 10595, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin II / pharmacology
Blood Gas Analysis
Heart / drug effects*
Hemodynamics / drug effects
Hemoglobins / pharmacology*
Myocardium / metabolism*
Nitric Oxide / physiology*
Oxygen Consumption / drug effects*
Regional Blood Flow / drug effects,  physiology
Vasoconstrictor Agents / pharmacology
Ventricular Function, Left / drug effects,  physiology
Grant Support
Reg. No./Substance:
0/Hemoglobins; 0/Vasoconstrictor Agents; 10102-43-9/Nitric Oxide; 11128-99-7/Angiotensin II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparative effects of bisoprolol and nitrendipine on exercise capacity in hypertensive patients wit...
Next Document:  The hemodynamic effects of adenosine infusion after experimental right heart infarct in young swine.